期刊文献+

N末端B型利钠肽前体在老年心力衰竭的诊断与预后中的应用价值 被引量:4

Application Value of N at the End of B Type Natriuretic Peptide Precursor in the Diagnosis and Prognosis of Senile Heart Failure
下载PDF
导出
摘要 目的探究N末端B型利钠肽前体的测定在老年心力衰竭患者的诊断及预后中的应用价值。方法选取我院住院部收治的老年心力衰竭患者与健康老年人进行对比研究,分析比较两组人员的N末端B型利钠肽前体水平。结果两组患者在血浆中的N末端B型利钠肽前体水平、左心室射血分数及左室舒末内径的比较上,P均<0.05,差异具有统计学意义。结论 N末端B型利钠肽前体对老年心力衰竭患者的诊断和预后具有重要意义。 Objective To explore the application value of N terminal B type natriuretic peptide precur-sor in the diagnosis and prognosis of older patients with heart failure. Methods Senile heart failure pa-tients of patient department in our hospital were selected as healthy subjects, N terminal level of B type natriuretic peptide precursor of two groups were compared. Results N terminal of plasma B type natri-uretic peptide precursor levels and left ventricular ejection fraction and left ventricular inner diameter at the end were compared, P<0.05, the difference was statistically significant. Conclusion The diagno-sis and prognosis of N terminal B type natriuretic peptide precursor of elderly patients with heart failure is of great significance.
出处 《现代诊断与治疗》 CAS 2014年第18期4090-4091,共2页 Modern Diagnosis and Treatment
关键词 N末端B型利钠肽前体 老年心力衰竭 应用价值 N terminal B type natriuretic peptide precursor Senile heart failure Application value
  • 相关文献

参考文献3

二级参考文献44

  • 1史晓敏,徐国宾,夏铁安.N末端B型钠尿肽原对充血性心力衰竭患者预后及危险分层评价的价值[J].中华检验医学杂志,2006,29(1):27-30. 被引量:56
  • 2McMurray JJ. Clinical practice[J].Systolic heart failure N Engl J Med,2010.228-238.
  • 3Chen J,Normand SL,Wang Y. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries,1998-2008[J].Journal of the American Medical Association,2011.1669-1678.
  • 4Dunlay SM,Redfield MM,Weston SA. Hospitalizations after heart failure diagnosis a community perspective[J].Journal of the American College of Cardiology,2009.1695-1702.
  • 5Shah AM,Mann DL. In search of new therapeutic targets and strategies for heart failure:recent advances in basic science[J].The Lancet,2011.704-712.
  • 6Gustafsson F,Steensgaard-Hansen F,Badskjaer J. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure[J].Journal of Cardiac Failure,2005.S15-S20.
  • 7Nielsen OW,Rasmussen V,Christensen N J. Neuroendocrine testing in community patients with heart disease:plasma N-terminal proatrial natriuretic peptide predicts morbidity and mortality stronger than catecholamines and heart rate variability[J].Scandinavian Journal of Clinical and Laboratory Investigation,2004.619-628.
  • 8Maisel A,Mueller C,Nowak R. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea:results from the BACH (Biomarkers in Acute Heart Failure) trial[J].Journal of the American College of Cardiology,2010.2062-2076.
  • 9Kelder JC,Cowie MR,McDonagh TA. Quantifying the added value of BNP in suspected heart failure in general practice:an individual patient data meta-analysis[J].Heart,2011.959-963.
  • 10Kelder JC,Cramer M J,Verweij WM. Clinical utility of three B-type natriuretic peptide assays for the initial diagnostic assessment of new slow-onset heart failure[J].Journal of Cardiac Failure,2011.729-734.

共引文献97

同被引文献24

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部